ABMD
Neuberger Berman Group’s Abiomed Inc ABMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-4,173
| Closed | -$1.03M | – | 1904 |
|
|
2022
Q3 | $1.03M | Buy |
4,173
+1,577
| +61% | +$388K | ﹤0.01% | 1249 |
|
|
2022
Q2 | $644K | Buy |
2,596
+1,197
| +86% | +$297K | ﹤0.01% | 1426 |
|
|
2022
Q1 | $464K | Buy |
1,399
+241
| +21% | +$79.9K | ﹤0.01% | 1557 |
|
|
2021
Q4 | $268K | Buy |
+1,158
| New | +$268K | ﹤0.01% | 1755 |
|
|
2019
Q3 | – | Sell |
-99,790
| Closed | -$26M | – | 1612 |
|
|
2019
Q2 | $26M | Sell |
99,790
-50,296
| -34% | -$13.1M | 0.03% | 535 |
|
|
2019
Q1 | $42.9M | Sell |
150,086
-582
| -0.4% | -$166K | 0.05% | 421 |
|
|
2018
Q4 | $49M | Buy |
150,668
+7,131
| +5% | +$2.32M | 0.07% | 364 |
|
|
2018
Q3 | $64.6M | Sell |
143,537
-19,275
| -12% | -$8.67M | 0.07% | 349 |
|
|
2018
Q2 | $66.6M | Sell |
162,812
-48,272
| -23% | -$19.7M | 0.07% | 345 |
|
|
2018
Q1 | $61.4M | Sell |
211,084
-39,253
| -16% | -$11.4M | 0.07% | 362 |
|
|
2017
Q4 | $46.9M | Sell |
250,337
-33,256
| -12% | -$6.23M | 0.05% | 427 |
|
|
2017
Q3 | $47.8M | Sell |
283,593
-255
| -0.1% | -$43K | 0.06% | 404 |
|
|
2017
Q2 | $40.7M | Buy |
283,848
+52,405
| +23% | +$7.51M | 0.05% | 430 |
|
|
2017
Q1 | $29M | Buy |
231,443
+89,183
| +63% | +$11.2M | 0.04% | 512 |
|
|
2016
Q4 | $16M | Buy |
142,260
+134,051
| +1,633% | +$15.1M | 0.02% | 643 |
|
|
2016
Q3 | $1.06M | Sell |
8,209
-3,500
| -30% | -$450K | ﹤0.01% | 1087 |
|
|
2016
Q2 | $1.28M | Buy |
11,709
+2,709
| +30% | +$296K | ﹤0.01% | 1037 |
|
|
2016
Q1 | $853K | Buy |
9,000
+6,515
| +262% | +$617K | ﹤0.01% | 1129 |
|
|
2015
Q4 | $224K | Buy |
+2,485
| New | +$224K | ﹤0.01% | 1427 |
|
|
2014
Q1 | – | Sell |
-8,220
| Closed | -$220K | – | 1679 |
|
|
2013
Q4 | $220K | Sell |
8,220
-2,707
| -25% | -$72.5K | ﹤0.01% | 1513 |
|
|
2013
Q3 | $208K | Buy |
+10,927
| New | +$208K | ﹤0.01% | 1511 |
|